|Bid||514.49 x 2200|
|Ask||522.01 x 800|
|Day's Range||513.78 - 523.00|
|52 Week Range||441.00 - 664.64|
|Beta (5Y Monthly)||0.19|
|PE Ratio (TTM)||14.70|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Regeneron (REGN) resumes enrollment in two patient cohorts of pipeline candidate, odronextamab, a CD20xCD3 bispecific antibody, after the FDA lifts partial clinical hold.
One simple way to benefit from the stock market is to buy an index fund. But if you pick the right individual stocks...
Bayer (BAYRY) enters a strategic deal with FUJIFILM Cellular Dynamics and Opsis Therapeutics to discover and develop cell therapies for addressing eye diseases.